Low
₹
High
₹
| Previous Close | ₹67.50 |
|---|---|
| Day's Range | ₹67.50 - ₹69.50 |
| Open | ₹69.50 |
| 52 Week Range | ₹36.58 - ₹87.91 |
| Volume | 67 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 0.05 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 6.11 |
| TTM EPS (₹) | 11.04 |
| P/E Ratio | 21.79 |
| Book Value(₹) | 1.34 |
| PAT Margin (%) | 8.38 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 7.16 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 13.88 | 65.28 |
| Expenses | N/A | N/A |
| PBT | 1.86 | 6.2 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1.41 | 4.97 |
| Founded | 1986 |
|---|
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,47,943.84 | 1,873.15 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,94,962.14 | 11,115.95 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,78,390.62 | 4,677.00 | 3,672.30 - 3,672.30 |
| Lenskart Solutions Ltd. | 1,27,829.39 | 752.05 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,25,900.72 | 8,792.60 | 6,696.50 - 6,696.50 |
| Laurus Labs Ltd. | 1,19,789.92 | 2,267.25 | 917.95 - 917.95 |
| Zydus Lifesciences Ltd. | 1,18,603.21 | 1,201.65 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,15,267.47 | 1,369.85 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,12,619.60 | 1,396.35 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,08,424.34 | 2,638.20 | 1,909.70 - 1,909.70 |
No Records Found
Colinz Laboratories has informed that the 40thAGM of the Members of the Company is scheduled to be held on Tuesday the 22nd September, 2026, at 2.30 PM (IST) through Video Conferencing ('VC')/ Other Audio-Visual Means (‘OAVM’), as per the directive(s) of Ministry of Corporate Affairs and Securities and Exchange Board of India. As per section 108 of Companies Act,2013, read with Rule 20 of the Companies (Management and Administration) Rule, 2014 and all applicable provisions of the SEBI (LODR) Regulations, 2015, the Company is pleased to provide to its members the facility to cast their Vote(s) through remote e-voting starting from 19th September, 2026 (9.00 am) to 21st September, 2026 (5.00 pm), the cut-off date for remote e-voting is 15th September, 2026. E voting facility will also be available during AGM, to those members who did not exercise e voting during the above period. Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 91 of the Companies Act, 2013, the company has enclosed the details of Book Closure dates and calendar of events related to the 40th AGM of the Company.
The above information is a part of company’s filings submitted to BSE.
In continuation to letter dated November 14, 2026, intimating approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, and pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Panacea Biotec has informed that it enclosed newspaper copies of the Extract of Statement of aforesaid Unaudited Financial Results published in the newspapers, Business Standard (English) and Desh Sewak (Punjabi) on November 16, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Colinz Laboratories Ltd. is ₹67.50 as of 2026-11-16.
The market capitalisation of Colinz Laboratories Ltd. is ₹17.00 as of 2026-11-16.
The 1-year return of Colinz Laboratories Ltd. is 24.76% as of 2026-11-16.
The P/E ratio of Colinz Laboratories Ltd. is 21.79 as of 2026-11-17.
The 52-week high and low of Colinz Laboratories Ltd. are ₹87.91 and ₹36.58, respectively, as of 2026-11-16.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.